Archives

Cardiol Therapeutics’ Phase II MAvERIC Results Accepted for Publication in the Journal of the American Heart Association

B Results demonstrate CardiolRx™ may represent a paradigm shift in the treatment of patients with recurrent pericarditis and further validate the ongoing Phase III trial,… Login to continue reading Login…

Read MoreCardiol Therapeutics’ Phase II MAvERIC Results Accepted for Publication in the Journal of the American Heart Association